The androgen-responsiveness of the p21 promoter in prostate cancer cells is also due to AR/Sp1 interaction [72], whereas the induction of the AR coactivator, nuclear receptor interaction protein (NRIP), involves AR-Sp, which includes an androgen response element (ARE) and GC-rich sites [73]. The gene discussed is SP1; the disease is prostate carcinoma.